MetaADEDB 2.0 @ LMMD
1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine
(PLRACCBDVIHHLZ-UHFFFAOYSA-N)
Structure
SMILES
CN1CCC(=CC1)c1ccccc1
Molecular Formula:
C12H15N
Molecular Weight:
173.254
Log P:
2.3434
Hydrogen Bond Acceptor:
1
Hydrogen Bond Donor:
0
TPSA:
3.24
CAS Number(s):
28289-54-5
Synonym(s)
1.
1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine
2.
MPTP
3.
N-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine
External Link(s)
MeSHD015632
PubChem Compound1388
BindingDB50003599
ChEBI17963
CHEMBLCHEMBL24172
KEGGcpd:C04599
Therapeutic Target DatabaseD01GAX
ZINC968184
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Ataxia30529163CTD
2Brain Diseases12360538
19666045
CTD
3Brain Injuries

View details

CTD
4Catalepsy24995576
30195017
30529163
CTD
5Catatonia12732244
24768735
CTD
6Dyskinesia, Drug-Induced

View details

CTD
7Gait Disorders, Neurologic22891246
23754278
CTD
8Gliosis31381935CTD
9Hypokinesia

View details

CTD
10Lameness, Animal30529163CTD
11MPTP Poisoning

View details

CTD
12Memory Disorders10727642CTD
13Mobility Limitation25053526CTD
14Motor Skills Disorders23943375CTD
15Movement Disorders

View details

CTD
16Muscle Rigidity15111244CTD
17Muscle Weakness28185818
31381935
CTD
18Nerve Degeneration

View details

CTD
19Neurobehavioral Manifestations24995576
28185818
CTD
20Neurologic Manifestations23062100CTD
21Neurotoxicity Syndromes16725203
18577399
27182044
CTD
22Parkinson Disease

View details

CTD
23Parkinsonian Disorders

View details

CTD
24Tremor1350061CTD
25Wallerian Degeneration31381935CTD
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120234

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.